The investigation of efficacy and safety of Aerius to seasonal allergic rhinitis.
- Author:
Xuejun YOU
1
;
Zheng LIU
;
Kai XU
;
Qixue GAO
;
Yonghua CUI
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. drxjyou@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Anti-Allergic Agents;
adverse effects;
therapeutic use;
Child;
Female;
Histamine H1 Antagonists;
adverse effects;
therapeutic use;
Humans;
Loratadine;
adverse effects;
analogs & derivatives;
therapeutic use;
Male;
Middle Aged;
Rhinitis, Allergic, Seasonal;
drug therapy;
Treatment Outcome;
Young Adult
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2008;22(8):382-384
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the efficacy and safety of Aerius to seasonal allergic rhinitis.
METHOD:Using randomized, controlled method, treatment group 40 cases, oral administration Aerius 5 mg/d for 12 days; control group 35 cases, oral administration Aerius 5 mg/d for 12 days, investigating their efficacy and safety.
RESULT:The total effective rate of treatment group was 92.50%, while control group was 85.71%, there was significant difference between them (P<0.05). Significant improvements of seasonal allergic rhinitis nasal obstruction were seen in treatment group after using Aerius (P<0.05). The incidence of side effect of treatment group was 2.50%.
CONCLUSION:Aerius is safe and can effectively reduction in nasal and nonnasal symptoms in patients with seasonal allergic rhinitis.
